Identifying reference chemicals for thyroid bioactivity screening

Reproductive Toxicology

Volumn 65, Issue , 2016, Pages 402-413

  Wegner, Susanna ^a   Browne, Patience ^b   Dix, David ^b  

^a OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Amphibian metamorphosis assay; Performance based validation; Rat pubertal assay; Reference chemicals; Thyroid

Indexed keywords

ENDOCRINE DISRUPTOR;

AMPHIBIA; AMPHIBIAN METAMORPHOSIS ASSAY; ARTICLE; BIOASSAY; BIOLOGICAL ACTIVITY; CHEMICAL ANALYSIS; FEMALE PUBERTAL RAT ASSAY; HIGH THROUGHPUT SCREENING; HISTOPATHOLOGY; IN VITRO STUDY; INFORMATION PROCESSING; MALE PUBERTAL RAT ASSAY; NONHUMAN; RODENT; SCREENING TEST; THYROID FUNCTION; THYROID WEIGHT; TOXICITY ASSAY; VALIDATION STUDY; ANIMAL; DRUG EFFECTS; HUMAN; STANDARDS; THYROID GLAND;

ANIMALS; BIOLOGICAL ASSAY; ENDOCRINE DISRUPTORS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; THYROID GLAND;

EID: 84988844615     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2016.08.016     Document Type: Article

References (98)

1. [1] FQPA, Food Quality Protection Act of 1996. Public Law 104–170, Available from: http://www.gpo.gov/fdsys/pkg/PLAW-104publ170/content-detail.html.
2. [2] SDWA, The Safe Drinking Waster Act Amendments of 1996. Public Law 104–182, Available from: http://www.gpo.gov/fdsys/pkg/PLAW-104publ182/pdf/PLAW-104publ182.pdf.
3. [3] EPA, Endocrine Disruption Screening Program (EDSP) Overview. https://www.epa.gov/endocrine-disruption/endocrine-disruptor-screening-program-edsp-overview, (accessed 27.05.16).
4. [4] EPA, Endocrine Disruptor Screening Program Universe of Chemicals and General Validation Principles. 2012 (accessed 27.05.16) https://www.epa.gov/sites/production/files/2015-07/documents/edsp_chemical_universe_and_general_validations_white_paper_11_12.pdf.
5. [5] EPA, Endocrine Disruptor Screening Program Tier 1 Assessments. 2015 (accessed 27.05.16) http://www2. epa.gov/ingredients-used-pesticide-products/endocrine-disruptor-screening-program-tier-1-assessments.
6. [6] EPA, Toxicity Forecasting. http://www.epa.gov/comptox/toxcast/, (accessed 31.05.16).
7. [7] Judson, R.S., Magpantay, F.M., Chickarmane, V., Haskell, C., Tania, N., Taylor, J., Xia, M., Huang, R., Rotroff, D.M., Filer, D.L., Houck, K.A., Martin, M.T., Sipes, N., Richard, A.M., Mansouri, K., Setzer, R.W., Knudsen, T.B., Crofton, K.M., Thomas, R.S., Integrated model of chemical perturbations of a biological pathway using 18 in vitro high throughput screening assays for the estrogen receptor. Toxicol. Sci., 2015, 10.1093/toxsci/kfv168.
8. [8] Browne, P., Judson, R.S., Casey, W.M., Kleinstreuer, N.C., Thomas, R.S., Screening chemicals for estrogen receptor bioactivity using a computational model. Environ. Sci. Technol. 49:14 (2015), 8804–8814, 10.1021/acs.est.5b02641.
9. ®ER (BG1Luc ER TA) Test Method: An In Vitro Assay for Identifying Human Estrogen Receptor Agonist and Antagonist Activity of Chemicals. 2011, NIEHS.
10. [10] Kleinstreuer, N.C., Ceger, P.C., Allen, D.G., Strickland, J., Chang, X., Hamm, J.T., Casey, W.M., A curated database of rodent uterotrophic bioactivity. Environ. Health Perspect., 2015, 10.1289/ehp.1510183.
11. [11] EPA, Use of High Throughput Assays and Computational Tools; Endocrine Disruptor Screening Program; Notice of Availability and Opportunity for Comment. 2015 (accessed 27.05.16) https://www.federalregister.gov/articles/2015/06/19/2015-15182/use-of-high-throughput-assays-and-computational-tools-endocrine-disruptor-screening-program-notice.
12. [12] Duntas, L.H., Chemical contamination and the thyroid. Endocrine 48:1 (2015), 53–64, 10.1007/s12020-014-0442-4.
13. [13] Crofton, K.M., Thyroid disrupting chemicals: mechanisms and mixtures. Int. J. Androl. 31:2 (2008), 209–223, 10.1111/j.1365-2605.2007.00857.x.
14. [14] Murk, A.J., Rijntjes, E., Blaauboer, B.J., Clewell, R., Crofton, K.M., Dingemans, M.M., Furlow, J.D., Kavlock, R., Kohrle, J., Opitz, R., Traas, T., Visser, T.J., Xia, M., Gutleb, A.C., Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals. Toxicol. In Vitro 27:4 (2013), 1320–1346, 10.1016/j.tiv.2013.02.012.
15. [15] OECD, New Scoping Document on in Vitro and Ex Vivo Assays for the Identification of Modulators of Thyroid Hormone Signalling No. 207. 2014.
16. [16] Tan, S.W., Zoeller, R.T., Integrating basic research on thyroid hormone action into screening and testing programs for thyroid disruptors. Crit. Rev. Toxicol. 37:1–2 (2007), 5–10, 10.1080/10408440601123396.
17. [17] Wirth, E.K., Schweizer, U., Kohrle, J., Transport of thyroid hormone in brain. Front. Endocrinol., 5, 2014, 98, 10.3389/fendo.2014.00098.
18. [18] Ishihara, A., Sawatsubashi, S., Yamauchi, K., Endocrine disrupting chemicals: interference of thyroid hormone binding to transthyretins and to thyroid hormone receptors. Mol. Cell. Endocrinol. 199:1-2 (2003), 105–117.
19. [19] Darras, V.M., Van Herck, S.L., Iodothyronine deiodinase structure and function: from ascidians to humans. J. Endocrinol. 215:2 (2012), 189–206, 10.1530/joe-12-0204.
20. [20] Veldhoen, N., Propper, C.R., Helbing, C.C., Enabling comparative gene expression studies of thyroid hormone action through the development of a flexible real-time quantitative PCR assay for use across multiple anuran indicator and sentinel species. Aquat. Toxicol. 148 (2014), 162–173, 10.1016/j.aquatox.2014.01.008.
21. [21] Boas, M., Feldt-Rasmussen, U., Main, K.M., Thyroid effects of endocrine disrupting chemicals. Mol. Cell. Endocrinol. 355:2 (2012), 240–248, 10.1016/j.mce.2011.09.005.
22. [22] Paschke, R., Molecular pathogenesis of nodular goiter. Langenbeck's Arch. Surg. 396:8 (2011), 1127–1136, 10.1007/s00423-011-0788-5.
23. [23] Brent, G.A., Environmental exposures and autoimmune thyroid disease. Thyroid 20:7 (2010), 755–761, 10.1089/thy.2010.1636.
24. [24] Iwen, K.A., Schroder, E., Brabant, G., Thyroid hormones and the metabolic syndrome. Eur. Thyroid J. 2:2 (2013), 83–92, 10.1159/000351249.
25. [25] Bassett, J.H., Williams, G.R., Role of thyroid hormones in skeletal development and bone maintenance. Endocr. Rev. 37:2 (2016), 135–187, 10.1210/er.2015-1106.
26. [26] Nazarpour, S., Ramezani Tehrani, F., Simbar, M., Azizi, F., Thyroid dysfunction and pregnancy outcomes. Iran. J. Reprod. Med. 13:7 (2015), 387–396.
27. [27] Krassas, G.E., Poppe, K., Glinoer, D., Thyroid function and human reproductive health. Endocr. Rev. 31:5 (2010), 702–755, 10.1210/er.2009-0041.
28. [28] Howdeshell, K.L., A model of the development of the brain as a construct of the thyroid system. Environ. Health Perspect. 110:Suppl (3) (2002), 337–348.
29. [29] Patel, J., Landers, K., Li, H., Mortimer, R.H., Richard, K., Thyroid hormones and fetal neurological development. J. Endocrinol. 209:1 (2011), 1–8, 10.1530/joe-10-0444.
30. [30] Bernal, J., Thyroid hormones and brain development. Vitam. Horm. 71 (2005), 95–122, 10.1016/S0083-6729(05)71004-9.
31. [31] Korevaar, T.I., Muetzel, R., Medici, M., Chaker, L., Jaddoe, V.W., de Rijke, Y.B., Steegers, E.A., Visser, T.J., White, T., Tiemeier, H., Peeters, R.P., Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study. Lancet Diabetes Endocrinol. 4:1 (2016), 35–43, 10.1016/s2213-8587(15)00327-7.
32. [32] Rastogi, M.V., LaFranchi, S.H., Congenital hypothyroidism. Orphanet J. Rare Dis., 5, 2010, 17, 10.1186/1750-1172-5-17.
33. [33] Kloas, W., Urbatzka, R., Opitz, R., Wurtz, S., Behrends, T., Hermelink, B., Hofmann, F., Jagnytsch, O., Kroupova, H., Lorenz, C., Neumann, N., Pietsch, C., Trubiroha, A., Van Ballegooy, C., Wiedemann, C., Lutz, I., Endocrine disruption in aquatic vertebrates. Ann. N. Y. Acad. Sci. 1163 (2009), 187–200, 10.1111/j.1749-6632.2009.04453.x.
34. [34] OECD, Test No. 231: Amphibian Metamorphosis Assay. 2009 http://www.oecd-ilibrary.org/environment/test-no-231-amphibian-metamorphosis-assay_9789264076242-en.
35. [35] EPA, Endocrine Disruptor Screening Program Test Guidelines: OPPTS 890.1100: Amphibian Metamorphosis Assay. 2009 Available from: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2009-0576-0002.
36. [36] EPA, Endocrine Disruptor Screening Program Test Guidelines OPPTS 890.1450:Pubertal Development and Thyroid Function in Intact Juvenile/Peripubertal Female Rats. 2009 Available from: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2009-0576-0009.
37. [37] EPA, Endocrine Disruptor Screening Program Test Guidelines OPPTS 890.1500: Pubertal Development and Thyroid Function InIntact Juvenile/Peripubertal Male Rats. 2009 Available from: http://www.regulations.gov/#!documentDetail;D=EPA-HQ-OPPT-2009-0576-0010.
38. [38] OECD, Validation of the Amphibian Metamorphosis Assay as a Screen for Thyroid-active Chemicals: Integrated Summary Report., 2007 Available from: https://www.epa.gov/endocrine-disruption/library.
39. [39] EPA, Integrated Summary Report for Validation of a Test Method for Assessment of Pubertal Development and Thyroid Function in Juvenile Male Rats as a Potencial Screen in the EDSP Tier 1 Battery., 2007 Available from: https://www.epa.gov/endocrine-disruption/library.
40. [40] EPA, Integrated Summary Report for Validation of a Test Method for Assessment of Pubertal Development and Thyroid Function in Juvenile Female Rats as a Potencial Screen in the EDSP Tier 1 Battery., 2007 Available from: https://www.epa.gov/endocrine-disruption/library.
41. [41] EPA, Series 9890- Endocrine Disruptor Screening Program Test Guidelines. https://www.epa.gov/test-guidelines-pesticides-and-toxic-substances/series-890-endocrine-disruptor-screening-program, (accessed 31.05.16).
42. [42] EPA, Toxicity Reference Database (ToxRefDB). http://www.epa.gov/chemical-research/toxicity-forecaster-toxcasttm-data, (accessed 31.05.16).
43. [43] NIEHS, Chemical Effects in Biological Systems (CEBS) Database. http://www.niehs.nih.gov/research/resources/databases/cebs/index.cfm, (accessed 31.05.16).
44. [44] EPA, ECOTOXicology knowledgebase. http://cfpub.epa.gov/ecotox/, (accessed 31.05.16).
45. [45] Marchesini, G.R., Meimaridou, A., Haasnoot, W., Meulenberg, E., Albertus, F., Mizuguchi, M., Takeuchi, M., Irth, H., Murk, A.J., Biosensor discovery of thyroxine transport disrupting chemicals. Toxicol. Appl. Pharmacol. 232:1 (2008), 150–160, 10.1016/j.taap.2008.06.014.
46. [46] Roberts, S.C., Noyes, P.D., Gallagher, E.P., Stapleton, H.M., Species-specific differences and structure-activity relationships in the debromination of PBDE congeners in three fish species. Environ. Sci. Technol. 45:5 (2011), 1999–2005, 10.1021/es103934x.
47. [47] Brodeur, J.C., Sassone, A., Hermida, G.N., Codugnello, N., Environmentally-relevant concentrations of atrazine induce non-monotonic acceleration of developmental rate and increased size at metamorphosis in Rhinella arenarum tadpoles. Ecotoxicol. Environ. Saf. 92 (2013), 10–17, 10.1016/j.ecoenv.2013.01.019.
48. [48] Coady, K., Murphy, M., Villeneuve, D., Hecker, M., Jones, P., Carr, J., Solomon, K., Smith, E., Van Der Kraak, G., Kendall, R., Giesy, J., Effects of atrazine on metamorphosis, growth, and gonadal development in the green frog (Rana clamitans). J. Toxicol. Environ. Health A 67:12 (2004), 941–957, 10.1080/15287390490443722.
49. [49] Rayner, J.L., Wood, C., Fenton, S.E., Exposure parameters necessary for delayed puberty and mammary gland development in Long-Evans rats exposed in utero to atrazine. Toxicol. Appl. Pharmacol. 195:1 (2004), 23–34, 10.1016/j.taap.2003.11.005.
50. [50] Storrs, S.I., Semlitsch, R.D., Variation in somatic and ovarian development: predicting susceptibility of amphibians to estrogenic contaminants. Gen. Comp. Endocrinol. 156:3 (2008), 524–530, 10.1016/j.ygcen.2008.03.001.
51. [51] Decherf, S., Seugnet, I., Fini, J.B., Clerget-Froidevaux, M.S., Demeneix, B.A., Disruption of thyroid hormone-dependent hypothalamic set-points by environmental contaminants. Mol. Cell. Endocrinol. 323:2 (2010), 172–182, 10.1016/j.mce.2010.04.010.
52. [52] Rossi, M., Dimida, A., Dell'anno, M.T., Trincavelli, M.L., Agretti, P., Giorgi, F., Corsini, G.U., Pinchera, A., Vitti, P., Tonacchera, M., Maggio, R., The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor. J. Pharmacol. Exp. Ther. 320:1 (2007), 465–474, 10.1124/jpet.106.113613.
53. [53] Santini, F., Vitti, P., Ceccarini, G., Mammoli, C., Rosellini, V., Pelosini, C., Marsili, A., Tonacchera, M., Agretti, P., Santoni, T., Chiovato, L., Pinchera, A., In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J. Endocrinol. Invest. 26:10 (2003), 950–955, 10.1007/bf03348190.
54. [54] Chen, A., Kim, S.S., Chung, E., Dietrich, K.N., Thyroid hormones in relation to lead, mercury, and cadmium exposure in the National Health and Nutrition Examination Survey, 2007–2008. Environ. Health Perspect. 121:2 (2013), 181–186, 10.1289/ehp.1205239.
55. [55] Luo, J., Hendryx, M., Relationship between blood cadmium, lead, and serum thyroid measures in US adults − the National Health and Nutrition Examination Survey (NHANES) 2007–2010. Int. J. Environ. Health Res. 24:2 (2014), 125–136, 10.1080/09603123.2013.800962.
56. [56] Palazzolo, D.L., Ely, E.A., Arsenic trioxide and reduced glutathione act synergistically to augment inhibition of thyroid peroxidase activity in vitro. Biol. Trace Elem. Res. 165:1 (2015), 110–117, 10.1007/s12011-015-0230-x.
57. [57] Chaurasia, S.S., Gupta, P., Kar, A., Maiti, P.K., Free radical mediated membrane perturbation and inhibition of type-I iodothyronine 5'-monodeiodinase activity by lead and cadmium in rat liver homogenate. Biochem. Mol. Biol. Int. 39:4 (1996), 765–770.
58. [58] OECD, Guidance Document on the Validation and International Acceptable of New or Updated Test Methods for Hazard Assessment, OECD Series on Testing and Assessment Number 34. 2005 Available from: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?doclanguage=en&cote=env/jm/mono%282005%2914.
59. [59] OECD, Test No.455: Performance-Based Test Guideline for Stably Transfected Transactivation In Vitro Assays to Detect Estrogen Receptor Agonists OECD Guidelines for the Testing of Chemicals, Section 4. 2012, OECD Publishing, Paris Available from: http://www.oecd-ilibrary.org/environment/test-no-455-performance-based-test-guideline-for-stably-transfected-transactivation-in-vitro-assays-to-detect-estrogen-receptor-agonists_9789264185388-en.
60. [60] OECD, Report on the Validation of the Amphibian Metamorphosis Assay. Series on Testing and Assessment, Numbers 76, 77, 91, and 92., 2008 Available from: http://www.oecd.org/chemicalsafety/testing/seriesontestingandassessmentecotoxicitytesting.htm.
61. [61] EPA, EDSP Dashboard. http://actor.epa.gov/edsp21/ (accessed 31.05.16).
62. [62] Paul, K.B., Hedge, J.M., Rotroff, D.M., Hornung, M.W., Crofton, K.M., Simmons, S.O., Development of a thyroperoxidase inhibition assay for high-throughput screening. Chem. Res. Toxicol. 27:3 (2014), 387–399, 10.1021/tx400310w.
63. [63] Paul Friedman, K., Watt, E.D., Hornung, M.W., Hedge, J.M., Judson, R.S., Crofton, K.M., Houck, K.A., Simmons, S.O., Tiered high-throughput screening approach to identify thyroperoxidase inhibitors within the ToxCast phase I and II chemical libraries. Toxicol. Sci., 2016, 10.1093/toxsci/kfw034.
64. [64] Paul, K.B., Hedge, J.M., Macherla, C., Filer, D.L., Burgess, E., Simmons, S.O., Crofton, K.M., Hornung, M.W., Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat. Toxicology 312 (2013), 97–107, 10.1016/j.tox.2013.08.006.
65. [65] Schmutzler, C., Bacinski, A., Gotthardt, I., Huhne, K., Ambrugger, P., Klammer, H., Schlecht, C., Hoang-Vu, C., Gruters, A., Wuttke, W., Jarry, H., Kohrle, J., The ultraviolet filter benzophenone 2 interferes with the thyroid hormone axis in rats and is a potent in vitro inhibitor of human recombinant thyroid peroxidase. Endocrinology 148:6 (2007), 2835–2844, 10.1210/en.2006-1280.
66. [66] Song, M., Kim, Y.J., Song, M.K., Choi, H.S., Park, Y.K., Ryu, J.C., Identification of classifiers for increase or decrease of thyroid peroxidase activity in the FTC-238/hTPO recombinant cell line. Environ. Sci. Technol. 45:18 (2011), 7906–7914, 10.1021/es200475k.
67. [67] Doerge, D.R., Takazawa, R.S., Mechanism of thyroid peroxidase inhibition by ethylenethiourea. Chem. Res. Toxicol. 3:2 (1990), 98–101.
68. [68] Marinovich, M., Guizzetti, M., Ghilardi, F., Viviani, B., Corsini, E., Galli, C.L., Thyroid peroxidase as toxicity target for dithiocarbamates. Arch. Toxicol. 71:8 (1997), 508–512.
69. [69] Sinha, N., Lal, B., Singh, T.P., Thyroid physiology impairment by malathion in the freshwater catfish Clarias batrachus. Ecotoxicol. Environ. Saf. 24:1 (1992), 17–25.
70. [70] Carr, D.L., Carr, J.A., Willis, R.E., Pressley, T.A., A perchlorate sensitive iodide transporter in frogs. Gen. Comp. Endocrinol. 156:1 (2008), 9–14, 10.1016/j.ygcen.2008.01.005.
71. [71] Petrich, T., Helmeke, H.J., Meyer, G.J., Knapp, W.H., Potter, E., Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. Eur. J. Nucl. Med. Mol. Imaging 29:7 (2002), 842–854, 10.1007/s00259-002-0784-7.
72. [72] Tonacchera, M., Agretti, P., Ceccarini, G., Lenza, R., Refetoff, S., Santini, F., Pinchera, A., Chiovato, L., Vitti, P., Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. Eur. J. Endocrinol. 144:6 (2001), 611–618.
73. [73] Ajjan, R.A., Findlay, C., Metcalfe, R.A., Watson, P.F., Crisp, M., Ludgate, M., Weetman, A.P., The modulation of the human sodium iodide symporter activity by Graves' disease sera. J. Clin. Endocrinol. Metab. 83:4 (1998), 1217–1221, 10.1210/jcem.83.4.4701.
74. [74] Barter, R.A., Klaassen, C.D., Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats. Toxicol. Appl. Pharmacol. 128:1 (1994), 9–17, 10.1006/taap.1994.1174.
75. [75] Van den Berg, K.J., van Raaij, J.A., Bragt, P.C., Notten, W.R., Interactions of halogenated industrial chemicals with transthyretin and effects on thyroid hormone levels in vivo. Arch. Toxicol. 65:1 (1991), 15–19.
76. [76] Cheek, A.O., Kow, K., Chen, J., McLachlan, J.A., Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. Environ. Health Perspect. 107:4 (1999), 273–278.
77. [77] Meerts, I.A., van Zanden, J.J., Luijks, E.A., van Leeuwen-Bol, I., Marsh, G., Jakobsson, E., Bergman, A., Brouwer, A., Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicol. Sci. 6:1 (2000), 95–104.
78. [78] Kaplan, M.M., Utiger, R.D., Iodothyronine metabolism in rat liver homogenates. J. Clin. Invest. 61:2 (1978), 459–471, 10.1172/jci108957.
79. [79] De Sandro, V., Chevrier, M., Boddaert, A., Melcion, C., Cordier, A., Richert, L., Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats. Toxicol. Appl. Pharmacol. 111:2 (1991), 263–278.
80. [80] Renko, K., Hoefig, C.S., Hiller, F., Schomburg, L., Kohrle, J., Identification of iopanoic acid as substrate of type 1 deiodinase by a novel nonradioactive iodide-release assay. Endocrinology 153:5 (2012), 2506–2513, 10.1210/en.2011-1863.
81. [81] Szabo, D.T., Richardson, V.M., Ross, D.G., Diliberto, J.J., Kodavanti, P.R., Birnbaum, L.S., Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups. Toxicol. Sci. 107:1 (2009), 27–39, 10.1093/toxsci/kfn230.
82. [82] Maiti, P.K., Kar, A., Dimethoate inhibits extrathyroidal 5'-monodeiodination of thyroxine to 3,3',5-triiodothyronine in mice: the possible involvement of the lipid peroxidative process. Toxicol. Lett. 91:1 (1997), 1–6.
83. [83] Wyde, M.E., Kirwan, S.E., Zhang, F., Laughter, A., Hoffman, H.B., Bartolucci-Page, E., Gaido, K.W., Yan, B., You, L., Di-n-butyl phthalate activates constitutive androstane receptor and pregnane X receptor and enhances the expression of steroid-metabolizing enzymes in the liver of rat fetuses. Toxicol. Sci. 86:2 (2005), 281–290, 10.1093/toxsci/kfi204.
84. [84] Qatanani, M., Zhang, J., Moore, D.D., Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology 146:3 (2005), 995–1002, 10.1210/en.2004-1350.
85. [85] Saghir, S.A., Charles, G.D., Bartels, M.J., Kan, L.H., Dryzga, M.D., Brzak, K.A., Clark, A.J., Mechanism of trifluralin-induced thyroid tumors in rats. Toxicol. Lett. 180:1 (2008), 38–45, 10.1016/j.toxlet.2008.05.019.
86. [86] Zhou, T., Ross, D.G., DeVito, M.J., Crofton, K.M., Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicol. Sci. 1:1 (2001), 76–82.
87. [87] Pascual, A., Montiel, F., Aranda, A., Effects of iopanoic acid on thyroid hormone receptor, growth hormone production, and triiodothyronine generation from thyroxine in pituitary GH1 cells. Endocrinology 120:3 (1987), 1089–1096, 10.1210/endo-120-3-1089.
88. [88] Tuca, A., Giralt, M., Villarroya, F., Vinas, O., Mampel, T., Iglesias, R., Inhibition of iodothyronine 5'-deiodinase by iopanoic acid does not block nuclear T3 accumulation during rat fetal development. Pediatr. Res. 35:1 (1994), 91–95, 10.1203/00006450-199401000-00019.
89. [89] Galton, V.A., The role of 3,5,3'-triiodothyronine in the physiological action of thyroxine in the premetamorphic tadpole. Endocrinology 124:5 (1989), 2427–2433, 10.1210/endo-124-5-2427.
90. [90] Shimada, N., Yamauchi, K., Characteristics of 3,5,3'-triiodothyronine (T3)-uptake system of tadpole red blood cells: effect of endocrine-disrupting chemicals on cellular T3 response. J. Endocrinol. 183:3 (2004), 627–637, 10.1677/joe.1.05893.
91. [91] Guo, G.L., Choudhuri, S., Klaassen, C.D., Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pathways. J. Pharmacol. Exp. Ther. 300:1 (2002), 206–212.
92. [92] Li, N., Wang, D., Zhou, Y., Ma, M., Li, J., Wang, Z., Dibutyl phthalate contributes to the thyroid receptor antagonistic activity in drinking water processes. Environ. Sci. Technol. 44:17 (2010), 6863–6868, 10.1021/es101254c.
93. [93] Shi, W., Hu, X., Zhang, F., Hu, G., Hao, Y., Zhang, X., Liu, H., Wei, S., Wang, X., Giesy, J.P., Yu, H., Occurrence of thyroid hormone activities in drinking water from eastern China: contributions of phthalate esters. Environ. Sci. Technol. 46:3 (2012), 1811–1818, 10.1021/es202625r.
94. [94] Takagi, S., Hummel, B.C., Walfish, P.G., Thionamides and arsenite inhibit specific T3 binding to the hepatic nuclear receptor. Biochem. Cell Biol. 68:3 (1990), 616–621.
95. [95] Shen, O., Wu, W., Du, G., Liu, R., Yu, L., Sun, H., Han, X., Jiang, Y., Shi, W., Hu, W., Song, L., Xia, Y., Wang, S., Wang, X., Thyroid disruption by Di-n-butyl phthalate (DBP) and mono-n-butyl phthalate (MBP) in Xenopus laevis. PLoS One, 6(4), 2011, e19159, 10.1371/journal.pone.0019159.
96. [96] Moriyama, K., Tagami, T., Usui, T., Naruse, M., Nambu, T., Hataya, Y., Kanamoto, N., Li, Y.S., Yasoda, A., Arai, H., Nakao, K., Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription. J. Clin. Endocrinol. Metab. 92:3 (2007), 1066–1072, 10.1210/jc.2006-1621.
97. [97] Schmutzler, C., Gotthardt, I., Hofmann, P.J., Radovic, B., Kovacs, G., Stemmler, L., Nobis, I., Bacinski, A., Mentrup, B., Ambrugger, P., Gruters, A., Malendowicz, L.K., Christoffel, J., Jarry, H., Seidlova-Wuttke, D., Wuttke, W., Kohrle, J., Endocrine disruptors and the thyroid gland-a combined in vitro and in vivo analysis of potential new biomarkers. Environ. Health Perspect. 115:Suppl (1) (2007), 77–83, 10.1289/ehp.9369.
98. [98] Du, G., Shen, O., Sun, H., Fei, J., Lu, C., Song, L., Xia, Y., Wang, S., Wang, X., Assessing hormone receptor activities of pyrethroid insecticides and their metabolites in reporter gene assays. Toxicol. Sci. 116:1 (2010), 58–66, 10.1093/toxsci/kfq120.